<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416804</url>
  </required_header>
  <id_info>
    <org_study_id>BTDS_001</org_study_id>
    <nct_id>NCT02416804</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery</brief_title>
  <official_title>Postoperative Analgesia With Buprenorphine Transdermal System (BTDS) Versus Tramadol for Postoperative Pain Control and Quality of Life After Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Major purpose of this research is to evaluate the effect and usefulness of Buprenorphine
      transdermal system (MTDS) among the patients with lumbar spinal disease who was performed the
      single-level posterior lumbar fusion.

      After surgery, all the patients apply the patient-controlled analgesia. After three days of
      surgery, patients are divided into two groups.Group A is an experimental group that
      administer the BTDS after surgery, and Group B is a control group that take tramadol
      analgesics. If the patient's pain score exceeds the NRS 4, they can take the additional
      rescue medicine, acetaminophen.

      After the surgery, patient's pain score and quality of life would be recorded sequentially.
      The time of recording is postoperative 36 hours, 72 hours, 7 days, 2 weeks, 4 weeks, and 3
      months, respectively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity score : pain NRS scale</measure>
    <time_frame>3 months</time_frame>
    <description>We will estimate pain NRS scale at 36 hours, 72 hours, 7 days, 2 weeks, 4 weeks, and 3 months postoperatively.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Spinal Stenosis</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Buprenorphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Buprenorphine group : They will apply 3 days after the spine operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tramadol group : They will take a pill of tramadol analgesics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buprenorphine</intervention_name>
    <description>Buprenorphine transdermal patch Initial : 5 μg/hr Sequential increasing of dose : 5 μg/hr -&gt; 10 μg/hr -&gt; 15 (5+10) μg/hr -&gt; 20 μg/hr</description>
    <arm_group_label>Buprenorphine</arm_group_label>
    <other_name>Norspan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>Tramadol Initial : 150 mg/d Sequential increasing of dose : 150 mg/d -&gt; 200 mg/d -&gt; 250 mg/d -&gt; 300 mg/d</description>
    <arm_group_label>Tramadol</arm_group_label>
    <other_name>Zytram</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults over 20 years

          -  taking the lumbar spinal surgery : single-level, posterior fusion

          -  stay in hospital more than 2 days after operation

        Exclusion Criteria:

          -  pregnancy or breast-feeding

          -  allergy or contraindication to buprenorphine

          -  patient with decreased lung function

          -  patient with taking MAO inhibitor or anticonvulsant

          -  patient with brain lesion, or severe liver disease

          -  dependence in opioid drugs

          -  taking muscle relaxant or tranquilizer

          -  patient had taken buprenorphine preoperatively

          -  taking strong opioids before enrolling the study

          -  another severe source of pain except lumbar spine

          -  severe cardiovascular, pulmonary, or renal compromised patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ho-Joong Kim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin S. Yeom</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>buprenorphine</keyword>
  <keyword>transdermal system</keyword>
  <keyword>Pain, postoperative</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Spinal stenosis</keyword>
  <keyword>Posterior lumbar fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Buprenorphine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

